Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
aortic valve stenosis
complications
indications
technique
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
revised:
25
01
2020
received:
23
09
2019
accepted:
10
02
2020
pubmed:
26
2
2020
medline:
12
10
2021
entrez:
26
2
2020
Statut:
ppublish
Résumé
Even if un to improve long-term prognosis, balloon aortic valvuloplasty (BAV) may be useful in selected patients with symptomatic severe aortic stenosis either as a bridge to surgical or transcatheter valve replacement (aortic valve replacement [AVR] or transcatheter aortic valve implantation [TAVI]) or as a triage strategy for patients with uncertain indications. International guidelines recommend BAV as: a "bridge" to AVR/TAVI, a "trial" in patients with undetermined symptoms, or a "bridge-to-decision" in case of comorbidities. However, in clinical practice, BAV is also used as a palliative measure to improve hemodynamics and quality of life in many patients who are excluded from AVR/TAVI. Finally, BAV is often performed during TAVI to facilitate prosthesis delivery, optimize frame expansion, or for bioprosthetic valve fracture in selected valve-in-valve procedures. Technical innovations, which allow for a mini-invasive approach via transradial access and pacing delivered through the wire, have led to a decrease in complications over time. This review focuses on contemporary BAV with a specific emphasis on new indications, innovative techniques, and specific complex patient subgroups.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
E1033-E1042Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Bordoni B, Saia F, Ciuca C, et al. Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study. G Ital Cardiol. 2013;14(4):262-268.
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019; 380:1695-1705
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706-1715.
Eltchaninoff H, Durand E, Borz B, et al. Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: acute and long-term outcomes. Am Heart J. 2014;167(2):235-240.
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-2791.
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70(2):252-289.
Saia F, Marrozzini C, Ciuca C, et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention. 2013;8(12):1388-1397.
Araque JC, Greason KL, Suri RM, et al. The role of balloon aortic valvuloplasty in patients with aortic valve stenosis and Society of Thoracic Surgeons risk of 15% or higher. Ann Thorac Surg. 2016;101(2):592-597.
Maluenda G, Ben-Dor I, Laynez-Carnicero A, et al. Changes in mitral regurgitation after balloon aortic valvuloplasty. Am J Cardiol. 2011;108(12):1777-1782.
Saia F, Moretti C, Dall'Ara G, et al. Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: a new paradigm for the heart team decision making. J Geriatr Cardiol. 2016;13(6):475-482.
Saia F, Marrozzini C, Moretti C, et al. The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention. 2011;7(6):723-729.
Szerlip M, Arsalan M, Mack MC, et al. Usefulness of balloon aortic valvuloplasty in the management of patients with aortic stenosis. Am J Cardiol. 2017;120(8):1366-1372.
Saia F, Marrozzini C, Dall'Ara G, et al. How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? J Cardiovasc Med. 2010;11(10):727-732.
Moretti C, Chandran S, Vervueren PL, et al. Outcomes of patients undergoing balloon aortic valvuloplasty in the TAVI era: a multicenter registry. J Invasive Cardiol. 2015;27(12):547-553.
Khawaja MZ, Sohal M, Valli H, et al. Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era. Catheter Cardiovasc Interv. 2013;81(2):366-373.
Bordoni B, Moretti C, Marrozzini C, et al. Repeated aortic balloon valvuloplasty in elderly patients with aortic stenosis who are not candidates for definitive treatment. J Invasive Cardiol. 2015;27(12):E277-E284.
Agarwal A, Kini AS, Attanti S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol. 2005;95(1):43-47.
Pedersen WR, Goldenberg IF, Pedersen CW, et al. Balloon aortic valvuloplasty in high risk aortic stenosis patients with left ventricular ejection fractions <20%. Catheter Cardiovasc Interv. 2014;84(5):824-831.
Selle A, Figulla HR, Ferrari M, et al. Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion. Clin Res Cardiol. 2014;103(11):902-911.
Ben-Dor I, Pichard AD, Satler LF, et al. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc Interv. 2010;3(11):1150-1156.
Witzke C, Don CW, Cubeddu RJ, et al. Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it? Catheter Cardiovasc Interv. 2010;75(3):444-452.
Eugene M, Urena M, Abtan J, et al. Effectiveness of rescue percutaneous balloon aortic valvuloplasty in patients with severe aortic stenosis and acute heart failure. Am J Cardiol. 2018;121(6):746-750.
Martin GP, Sperrin M, Bagur R, et al. Pre-implantation balloon aortic valvuloplasty and clinical outcomes following transcatheter aortic valve implantation: a propensity score analysis of the UK registry. J Am Heart Assoc. 2017;6(2):e004695.
Chhatriwalla AK, Allen KB, Saxon JT, et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10(7):e005216.
Singh V, Patel NJ, Badheka AO, et al. Comparison of outcomes of balloon aortic valvuloplasty plus percutaneous coronary intervention versus percutaneous aortic balloon valvuloplasty alone during the same hospitalization in the United States. Am J Cardiol. 2015;115(4):480-486.
Leclercq F, Delseny D, Nogue E, et al. Decrease of vascular and bleeding complications after balloon aortic valvuloplasty performed without heparin. J Invasive Cardiol. 2014;26(10):528-533.
Dall'Ara G, Saia F, Moretti C, et al. Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017;89(4):E145-E152.
Piayda K, Wimmer AC, Veulemans V, et al. Balloon valvuloplasty followed by transcatheter aortic valve implantation as a staged procedure in patients with low-flow low-gradient aortic stenosis. J Invasive Cardiol. 2018;30(12):437-442.
McKay RG, Safian RD, Lock JE, et al. Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation. 1986;74(1):119-125.
Singh V, Yadav PK, Eng MH, et al. Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: results from the Global cVAD Registry. Int J Cardiol. 2017;240:120-125.
Laynez A, Ben-Dor I, Hauville C, et al. Frequency of cardiac conduction disturbances after balloon aortic valvuloplasty. Am J Cardiol. 2011;108(9):1311-1315.
Abramowitz Y, Jilaihawi H, Chakravarty T, et al. Feasibility and safety of balloon-expandable transcatheter aortic valve implantation with moderate or without predilatation. EuroIntervention. 2016;11(10):1132-1139.
Deharo P, Jaussaud N, Grisoli D, et al. Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the France TAVI registry. JACC Cardiovasc Interv. 2018;11(19):1956-1965.
Barbanti M, Sgroi C, Imme S, et al. Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study. EuroIntervention. 2014;10(2):241-247.
Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312(2):162-170.
Saxon JT, Allen KB, Cohen DJ, Chhatriwalla AK. Bioprosthetic valve fracture during valve-in-valve TAVR: bench to bedside. Interv Cardiol. 2018;13(1):20-26.
Allen KB, Chhatriwalla AK, Saxon JT, et al. Bioprosthetic valve fracture: technical insights from a multicenter study. J Thorac Cardiovasc Surg. 2019;158(5):1317-1328.
Nielsen-Kudsk JE, Andersen A, Therkelsen CJ, et al. High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation. EuroIntervention. 2017;13(9):e1020-e1025.
Daniec M, Nawrotek B, Sorysz D, et al. Acute and long-term outcomes of percutaneous balloon aortic valvuloplasty for the treatment of severe aortic stenosis. Catheter Cardiovasc Interv. 2017;90(2):303-310.
Ford TJ, Nguyen K, Brassil J, et al. Balloon aortic valvuloplasty in the transcatheter valve era: single centre indications and early safety data in a high risk population. Heart Lung Circ. 2018;27(5):595-600.
Gajanana D, Wheeler D, Hsi D, Kovach R, George JC. Percutaneous balloon aortic valvuloplasty and clinical outcomes in severe aortic stenosis: correlation of procedural technique and efficacy. J Interv Cardiol. 2016;29(6):612-618.
Dall'Ara G, Marzocchi A, Taglieri N, et al. Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: the pacing versus no pacing (PNP) study. J Interv Cardiol. 2018;31(1):51-59.
Douglas PS, Hahn RT, Pibarot P, et al. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. J Am Soc Echocardiogr. 2015;28(2):210-217.
Ben-Dor I, Maluenda G, Dvir D, et al. Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to transcatheter/surgical aortic valve replacement. Catheter Cardiovasc Interv. 2013;82(4):632-637.
Don CW, Witzke C, Cubeddu RJ, et al. Comparison of procedural and in-hospital outcomes of percutaneous balloon aortic valvuloplasty in patients >80 years versus patients < or =80 years. Am J Cardiol. 2010;105(12):1815-1820.
Christodoulidis G, Yu J, Kini A, et al. Gender-specific outcomes after balloon aortic valvuloplasty: inhospital and long-term outcomes. Am Heart J. 2015;170(1):180-186.
Attisano T, Silverio A, Stabile E, et al. Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: the "BAV for life" experience. Catheter Cardiovasc Interv. 2019;93(1):E63-E70.
Kapadia S, Stewart WJ, Anderson WN, et al. Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). JACC Cardiovasc Interv. 2015;8(2):324-333.
Badheka AO, Patel NJ, Singh V, et al. Percutaneous aortic balloon valvotomy in the United States: a 13-year perspective. Am J Med. 2014;127(8):744-753.
Dall'Ara G, Santarelli A, Marzocchi A, et al. Vascular complications after balloon aortic valvuloplasty in recent years: incidence and comparison of two hemostatic devices. Catheter Cardiovasc Interv. 2017;91(6):E49-E55.
O'Neill B, Singh V, Kini A, et al. The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: a sub-analysis of the BRAVO study. Catheter Cardiovasc Interv. 2014;83(1):148-153.
Ussia GP, Sarkar K, Tamburino C. Aortic valve perforation during aortic valvuloplasty: identification and strategies for prevention. Catheter Cardiovasc Interv. 2011;77(6):876-880.
Ali O, Salinger MH, Levisay JP, Feldman T. High pacing rates for management of aortic insufficiency after balloon aortic valvuloplasty or transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014;83(1):162-168.
Kini A, Yu J, Cohen MG, et al. Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty. EuroIntervention. 2014;10(3):312-319.
Hilling-Smith R, Cockburn J, Dooley M, et al. Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017;89(4):783-786.
Tumscitz C, Campo G, Tebaldi M, Gallo F, Pirani L, Biscaglia S. Safety and feasibility of transradial mini-invasive balloon aortic valvuloplasty: a pilot study. JACC Cardiovasc Interv. 2017;10(13):1375-1377.
Seto AH, Abu-Fadel MS, Sparling JM, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interv. 2010;3(7):751-758.
Debry N, Kone P, Vincent F, et al. Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. EuroIntervention. 2018;14(5):e519-e525.
Bongiovanni D, Kuhl C, Bleiziffer S, et al. Emergency treatment of decompensated aortic stenosis. Heart. 2018;104(1):23-29.
Di Segni E, Bakst A, Levi A, Rosenschein U, Klein HO. The mechanism of the obstruction in calcific aortic stenosis with bicuspid valve: a reason for failure of balloon aortic valvuloplasty in the elderly. Cardiology. 1989;76(6):450-454.
Gonzalez MA, Ben-Dor I, Maluenda G, Pichard AD, Satler LF, Waksman R. The impact of balloon aortic valvuloplasty on aortic regurgitation in patients with severe aortic stenosis. J Heart Valve Dis. 2012;21(6):724-731.
Saia F, Marrozzini C, Ciuca C, et al. Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? Catheter Cardiovasc Interv. 2012;79(2):315-321.